Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Mindray Medical International Ltd (ADR) Company Profile (NYSE:MR)

Consensus Ratings for Mindray Medical International Ltd (ADR) (NYSE:MR) (?)
Ratings Breakdown: 6 Hold Rating(s), 1 Buy Rating(s)
Consensus Rating:Hold (Score: 2.14)
Consensus Price Target: $34.55 (14.98% upside)

Analysts' Ratings History for Mindray Medical International Ltd (ADR) (NYSE:MR)
Show:
DateFirmActionRatingPrice TargetDetailsShare
6/26/2014ZacksDowngradeOutperform -> Neutral$33.00ViewTweet This Rating  Share This Rating on StockTwits
5/22/2014Jefferies GroupLower Price TargetHold$36.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
5/7/2014Bank of AmericaDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
5/6/2014Morgan StanleyReiterated RatingIn-LineViewTweet This Rating  Share This Rating on StockTwits
4/24/2014Credit SuisseUpgradeUnderperform -> NeutralViewTweet This Rating  Share This Rating on StockTwits
4/14/2014Morgan StanleyDowngradeOverweight -> Equal Weight$44.00 -> $37.00ViewTweet This Rating  Share This Rating on StockTwits
4/7/2014Goldman SachsDowngradeBuy -> Neutral$45.50 -> $31.20ViewTweet This Rating  Share This Rating on StockTwits
3/13/2014ZacksUpgradeHold -> BuyViewTweet This Rating  Share This Rating on StockTwits
3/11/2014ZacksReiterated RatingOutperform -> Outperform$38.00ViewTweet This Rating  Share This Rating on StockTwits
3/4/2014OppenheimerLower Price TargetOutperform$50.00 -> $42.00ViewTweet This Rating  Share This Rating on StockTwits
12/13/2013Bank of AmericaUpgradeBuyViewTweet This Rating  Share This Rating on StockTwits
11/6/2013Jefferies GroupLower Price TargetHold$43.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
11/4/2013Credit SuisseInitiated CoverageUnderperformViewTweet This Rating  Share This Rating on StockTwits
10/8/2013ZacksReiterated RatingNeutral -> Neutral$41.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013OppenheimerBoost Price Target$45.00 -> $50.00ViewTweet This Rating  Share This Rating on StockTwits
8/7/2013Credit SuisseDowngradeNeutral -> UnderperformViewTweet This Rating  Share This Rating on StockTwits
7/3/2013Piper JaffrayDowngradeOverweight -> Neutral$40.00ViewTweet This Rating  Share This Rating on StockTwits
6/6/2013ZacksReiterated RatingNeutral -> Neutral$42.00ViewTweet This Rating  Share This Rating on StockTwits
5/8/2013Bank of AmericaDowngradeBuy -> NeutralViewTweet This Rating  Share This Rating on StockTwits
3/18/2013HSBCDowngradeOverweight -> NeutralViewTweet This Rating  Share This Rating on StockTwits
3/6/2013Jefferies GroupDowngradeBuy -> Hold$36.00 -> $43.00ViewTweet This Rating  Share This Rating on StockTwits
2/27/2013OppenheimerBoost Price TargetOutperform$39.00 -> $45.00ViewTweet This Rating  Share This Rating on StockTwits
1/11/2013Goldman SachsUpgradeNeutral -> Buy$39.60ViewTweet This Rating  Share This Rating on StockTwits
1/3/2013Bank of AmericaUpgradeNeutral -> Buy$35.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
1/2/2013Credit AgricoleDowngradeOutperform -> Neutral$34.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
1/2/2013Credit SuisseDowngradeOutperform -> Neutral$34.00 -> $32.00ViewTweet This Rating  Share This Rating on StockTwits
12/31/2012OppenheimerReiterated RatingOutperform$39.00ViewTweet This Rating  Share This Rating on StockTwits
11/7/2012Jefferies GroupBoost Price TargetBuy -> Buy$34.00 -> $36.00ViewTweet This Rating  Share This Rating on StockTwits
10/5/2012OppenheimerReiterated RatingOutperform -> OutperformViewTweet This Rating  Share This Rating on StockTwits
8/20/2012OppenheimerBoost Price TargetOutperform$34.00 -> $39.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2012CICC ResearchBoost Price TargetBuy$35.00 -> $38.00ViewTweet This Rating  Share This Rating on StockTwits
8/8/2012BarclaysUpgradeEqual Weight -> Overweight$42.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 8/1/2012 forward)